LaserSight LaserScan LSX For LASIK Myopia Correction To Ship By Year-End
This article was originally published in The Gray Sheet
Executive Summary
LaserSight LaserScan LSX systems equipped for laser in-situ keratomileusis (LASIK) treatment of myopia with or without astigmatism will ship by year-end following FDA approval of the expanded indication.